HLA-DPA1 overexpression inhibits cancer progression, reduces resistance to cisplatin, and correlates with increased immune infiltration in lung adenocarcinoma
Figure 11.The association between the HLA-DPA1 overexpression and tumor purity and immune cells in LUAD using the TIMER database. Abbreviations: LUAD: lung adenocarcinoma; TIMER: Time Interval Medical Event Recorder.